{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:41:04Z","timestamp":1790887264334,"version":"4.1.0"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2010,1,1]]},"DOI":"10.1185\/03007990903396469","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T10:59:12Z","timestamp":1257937152000},"page":"61-69","source":"Crossref","is-referenced-by-count":121,"title":["Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients"],"prefix":"10.1185","volume":"26","author":[{"given":"Eric Q.","family":"Wu","sequence":"first","affiliation":[{"name":"Analysis Group Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Johnson","sequence":"additional","affiliation":[{"name":"Analysis Group Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Beaulieu","sequence":"additional","affiliation":[{"name":"Analysis Group Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateo","family":"Arana","sequence":"additional","affiliation":[{"name":"Analysis Group Inc., Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi","family":"Bollu","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Guo","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Coombs","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Feng","sequence":"additional","affiliation":[{"name":"Novartis Pharmaceuticals Corporation, Florham Park, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[{"name":"MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2009,11,11]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90124-3"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.8.895"},{"key":"CIT0003","unstructured":"Surveillance, Epidemiology and End Results, SEER. Median age of cancer patients at diagnosis. SEER Cancer Statistics Review 1975-2006, Accessed online at http:\/\/seer.cancer.gov\/csr\/1975_2006\/results_single\/sect_01_table.11_2pgs.pdf. last accessed on 6\/12\/09"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-3-199908030-00008"},{"key":"CIT0005","doi-asserted-by":"crossref","unstructured":"Cortes J, Baccarani M, Guilhot F, et al. A phase\u2009III, randomized, open-label study of 400\u2009mg versus 800\u2009mg of imatinib mesylate in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular endpoints: 1-year results of TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity) study. American Society of Hematology Annual Meeting, December 2008","DOI":"10.1182\/blood.V112.11.335.335"},{"key":"CIT0006","first-page":"85","volume":"25","author":"Nowell PC","year":"1960","journal-title":"J Natl Cancer Inst"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1038\/243290a0"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1126\/science.3460176"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(87)80032-X"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880401)61:7<1441::AID-CNCR2820610727>3.0.CO;2-C"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1068"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1038\/nm0596-561"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441401"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1928"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.10.3547"},{"key":"CIT0016","unstructured":"Horner MJ, Ries LAG, Krapcho M, et al. (eds). SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Accessed online at http:\/\/seer.cancer.gov\/csr\/1975_2006, last accessed on 6\/12\/09"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20922"},{"key":"CIT0018","unstructured":"O\u2019Brien S, Berman E, Bhalla K, et al. NCCN Clinical Practice Guidelines in Oncology: Chronic Myelogenous Leukemia: National Comprehensive Cancer Network, 2007"},{"key":"CIT0019","unstructured":"O\u2019Brien SG, Guilhot F, Druker BJ, et al. The IRIS study in early chronic phase CML: 7 year follow-up. American Society of Hematology Annual Meeting, December 2008"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Hochhaus A, O\u2019Brian SG, Guilhot F, et al. Six-year follow-up of patients receiving imatinib for first-line treatment of chronic myeloid leukemia. Leukemia 2009 March 12","DOI":"10.1038\/leu.2009.38"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036012"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.08.012"},{"key":"CIT0023","first-page":"31","volume":"19","author":"Lee WC","year":"2006","journal-title":"Manag Care Interface"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000163641.86870.af"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.07.071"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/94.9.652"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200306000-00017"},{"key":"CIT0028","first-page":"Abstract 4553","volume":"110","author":"Doti C","year":"2007","journal-title":"Blood (ASH Annual Meeting Abstracts)"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-196543"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0826"},{"key":"CIT0031","first-page":"1117","volume":"88","author":"Cervantes F","year":"2003","journal-title":"Haematologica"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011573"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.6.679"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.322"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.11.064"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-006-9193-0"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn646"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200725060-00004"},{"issue":"18","key":"CIT0039","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1200\/jco.2006.24.18_suppl.6119","volume":"24","author":"Tsang J","year":"2006","journal-title":"J Clin Oncol"},{"key":"CIT0040","unstructured":"Adamson D, Chang S, Hansen Leigh. White Paper: Health Research Data for the Real World: The MarketScan Databases. Thomson Healthcare, January 2008"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(92)90133-8"},{"key":"CIT0042","first-page":"449","volume":"11","author":"Sikka R","year":"2005","journal-title":"Am J Manag Care"},{"key":"CIT0043","unstructured":"Bureau of Labor Statistics. Measuring Price Change for Medical Care in CPI. Accessed online at http:\/\/www.bls.gov\/cpi\/cpifact4.htm, last accessed on 6\/12\/09"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(98)00025-3"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(01)00086-8"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(98)00030-7"},{"key":"CIT0047","unstructured":"Sackett DL, Haynes RB. Compliance With Therapeutic Regimens. Baltimore, MD: The Johns Hopkins University Press, 1976"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1972135part2841"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I"},{"key":"CIT0050","first-page":"592","volume":"6","author":"Greenberg RN.","year":"1984","journal-title":"Clin Ther"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01213.x"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra050100"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-197501000-00002"},{"key":"CIT0054","unstructured":"Becker MH. Sociobehavioral determinants of compliance. In: Sackett DL, Haynes RB, eds. Compliance With Therapeutic Regimens. Baltimore, MD: Johns Hopkins University Press, 1976:40-50"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007990903396469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T13:40:02Z","timestamp":1597585202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007990903396469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,11]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1,1]]}},"alternative-id":["10.1185\/03007990903396469"],"URL":"https:\/\/doi.org\/10.1185\/03007990903396469","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,11]]}}}